Generic OTC understanding
This article was originally published in The Tan Sheet
Two-thirds of American adults "recognize that 'store-brand' medicines will relieve symptoms as well as advertised brands," according to an online survey of 2,386 adults sponsored by Perrigo. Results also show 80% of consumers who buy store brands "use the 'compare to' information on the front of store brand packages." Still, nearly half of respondents said "symptoms relief" was the most important factor when choosing an OTC, while 12% said price was the main driver. Harris Interactive conducted the poll in May 2004 to "highlight key purchasing habits of OTC medicines"...
You may also be interested in...
Cosmetics Europe Talks Microplastic: ECHA Frustrations, ‘Value Judgments’ And International Trade Uncertainty
The European Chemicals Agency's microplastic restriction proposal received committee backing in 2020 without changes sought by the cosmetics industry, which faces €15bn in projected costs and scarce alternatives at present. It may come down to EU Member States to decide whether the ECHA restriction proposal is proportionate in balancing environmental goals and socio-economic impacts.
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.